Geode Capital Management, LLC Equillium, Inc. Transaction History
Geode Capital Management, LLC
- $1.24 Trillion
- Q1 2025
A detailed history of Geode Capital Management, LLC transactions in Equillium, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 205,367 shares of EQ stock, worth $67,771. This represents 0.0% of its overall portfolio holdings.
Number of Shares
205,367
Previous 204,385
0.48%
Holding current value
$67,771
Previous $161,000
50.31%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding EQ
# of Institutions
27Shares Held
11.3MCall Options Held
13.2KPut Options Held
100-
Decheng Capital LLC Menlo Park, CA4.45MShares$1.47 Million0.49% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC4.45MShares$1.47 Million1.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA842KShares$277,8420.0% of portfolio
-
Cota Capital Management, LLC San Francisco, CA562KShares$185,551100.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny270KShares$88,9350.0% of portfolio
About Equillium, Inc.
- Ticker EQ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,352,100
- Market Cap $11.3M
- Description
- Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...